futibatinib, fulvestrant clinical trials

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

This study is for cancer patients already taking the drug futibatinib in another study. It lets them continue treatment if it's helping and safe, ensuring ongoing care without interruption.